Merz Pharma Executive and Leadership Team

Kelly Hu, the Chief Financial Officer (China) at Merz Pharma, manages all fiscal planning and capital allocation strategies within the Asia Pacific region. Overseeing regional financial reporting, the Chief Financial Officer (China) ensures strict compliance with local regulatory frameworks while driving profitability. This leadership role involves analyzing market trends to inform investment decisions regarding aesthetic medicine distribution. By monitoring cash flow and managing regional budgets, Kelly Hu directly impacts the financial health of the Chinese affiliate. Hu coordinates with global leadership to align regional fiscal goals with the broader corporate mission. Through the rigorous assessment of economic risks, the Chief Financial Officer (China) protects assets and optimizes resource distribution. This financial oversight enables the company to expand market presence effectively. Ultimately, Hu provides the fiscal stability required to support ongoing research and development initiatives within the competitive pharmaceutical landscape.

Will Fridedman, the Chief Operating Officer at Merz Pharma, directs all internal manufacturing and supply chain logistics to ensure consistent product availability. Overseeing global production standards, the Chief Operating Officer maintains rigorous quality control across all pharmaceutical facilities. This leadership role involves optimizing operational workflows to support the development of aesthetic medicine and neurology products. By streamlining cross-functional processes, Will Fridedman directly impacts the efficiency of the entire organization. Fridedman manages the integration of complex distribution networks, ensuring that innovative treatments reach patients across Europe, the US, and emerging markets. Through the implementation of lean manufacturing principles, the Chief Operating Officer reduces waste while increasing output capacity. This strategic focus on operational excellence allows the company to scale production effectively. Ultimately, Fridedman secures the supply chain integrity necessary for sustained market growth and long-term pharmaceutical success.

Lawrence Siow, the President, Asia Pacific at Merz Pharma, directs all commercial activities and market expansion efforts throughout the Asia Pacific region. Overseeing regional sales teams, the President, Asia Pacific ensures the successful distribution of aesthetic medicine and neurology products. This leadership role involves building strategic partnerships with healthcare providers to increase brand awareness and market penetration. By analyzing regional consumer behavior, Lawrence Siow directly impacts the growth trajectory of the company in diverse markets. Siow coordinates with global headquarters to adapt product strategies to local regulatory and cultural requirements. Through the execution of targeted marketing campaigns, the President, Asia Pacific drives revenue growth and strengthens the company's competitive position. This focus on regional development allows for the effective scaling of innovative therapeutic solutions. Ultimately, Siow secures the long-term commercial success of the organization by fostering strong relationships with key stakeholders across the entire Asia Pacific territory.

Stefan Schacht, the Group Chief Information Officer, Merz & Group Senior VP, Strategic Sourcing at Merz Pharma, architects the digital infrastructure and procurement strategies necessary for global operations. Overseeing enterprise-wide technology integration, the Group Chief Information Officer, Merz & Group Senior VP, Strategic Sourcing ensures data security and system scalability. This leadership role involves managing complex vendor relationships to secure high-quality raw materials for pharmaceutical production. By digitizing procurement workflows, Stefan Schacht directly impacts the efficiency of the global supply chain. Schacht collaborates with executive leadership to implement advanced analytics that drive informed decision-making across all departments. Through the modernization of IT systems, the Group Chief Information Officer, Merz & Group Senior VP, Strategic Sourcing supports the research and development of innovative neurological treatments. This dual focus on technology and sourcing optimizes operational costs. Ultimately, Schacht maintains the robust digital and material foundation required for international market leadership.